Clinical Trial Update: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA) [Phase 1]

View source ↗

Summary

Phase 1 open-label pharmacokinetic study of iron isomaltoside 1000 (Monofer) given as a 500 mg IV bolus or 1000 mg IV infusion in patients with non-hematologica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Anemia

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Non-hematological Malignancies | Phase 1 | Status: COMPLETED